Samsrita Labs Limited (BOM:539267)

Market Cap	356.49M +20.7%
Revenue (ttm)	n/a
Net Income	-78.25M
EPS	-4.17
Shares Out	22.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	183
Average Volume	2,671
Open	16.65
Previous Close	15.86
Day's Range	15.08 - 16.65
52-Week Range	12.19 - 26.04
Beta	0.05
RSI	44.04
Earnings Date	Apr 24, 2026

About Samsrita Labs

Samsrita Labs Limited operates as a biopharmaceutical company in India. The company offers DNA, RNA, and chromosomal-based tests for oncology, pharmacogenomics, infectious diseases, genetic disorders, transplantation typing, and prenatal and pre-implantation genetic diagnostics; and quantitative/real-time polymerase chain reaction (qPCR), multiplex ligation-dependent probe amplification (MLPA), Sanger and Next Generation Sequencing (NGS), karyotype, and fluorescence in-situ hybridization analysis. It is also involved in the stem cell research a...

• Industry: Commercial Physical and Biological Research
• Founded: 1996
• Employees: 4
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539267